BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions

Trial Profile

BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Jun 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Arteriosclerosis; Peripheral artery restenosis; Peripheral vascular disorders
  • Focus Therapeutic Use
  • Acronyms BATTLE
  • Most Recent Events

    • 07 Jun 2017 Status changed from recruiting to active, no longer recruiting.
    • 07 Mar 2016 Planned End Date changed from 1 Mar 2018 to 1 Sep 2018, as reported by ClinicalTrials.gov.
    • 07 Mar 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Sep 2017, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top